N-Acetyl Semax 50mg/vial – US Stock

N-Acetyl Semax 50mg/vial – US Stock
N-Acetyl Semax 50 mg/vial from Hilma Biocare is a synthetic neuropeptide and modified form of Semax. The supplied product information describes it as an analogue of a fragment of adrenocorticotropic hormone (ACTH 4–10) without hormonal activity.
The product is supplied as an injection/powder formulation with 50 mg of N-Acetyl Semax per vial.
Product Overview
N-Acetyl Semax is described in the supplied material as a more stable and bioavailable modification of the Semax peptide. According to the source, the addition of an acetyl group is intended to increase stability and half-life.
The supplied specifications classify N-Acetyl Semax as a peptide hormone and list an active half-life of approximately 2–5 minutes. The product information describes no water retention and no aromatization.
Key Product Characteristics

Active Ingredient: N-Acetyl Semax
Strength: 50 mg
Form: Injection/Powder
Product Type: Peptide hormone
Subgroup: Peptide formulation
Pack Size: 1 vial
Active Half-Life: Approximately 2–5 minutes
Manufacturer/Brand: Hilma Biocare
Availability: US Stock
Water Retention: No, according to supplied specifications
Aromatization: No, according to supplied specifications

Product Specifications

Specification
Details

Brand
Hilma Biocare

Active Ingredient
N-Acetyl Semax

Strength
50 mg

Form
Injection/Powder

Product Type
Peptide Hormone

Pack Size
1 vial

Active Half-Life
2–5 minutes

Water Retention
No, according to supplied specifications

Aromatization
No, according to supplied specifications

Availability
US Stock

Product Characteristics
The supplied description characterizes N-Acetyl Semax as a regulatory peptide with nootropic, neuroprotective, antioxidant, and antihypoxic properties. The source discusses its relationship with concentration, memory, learning, brain-derived neurotrophic factor (BDNF), neuronal protection, and recovery following neurological injury.
The supplied material also describes research and medical use in areas including stroke, transient ischemic attack, cognitive impairment, optic nerve disorders, and neurological rehabilitation. These statements reflect the supplied source and are not presented as guaranteed therapeutic outcomes or personalized medical claims.
Application
The supplied product information describes intranasal and subcutaneous routes of administration. It states that intranasal administration is intended for rapid absorption, while subcutaneous administration involves injection into fatty tissue.
Because N-Acetyl Semax is a biologically active neuropeptide, administration should be determined by an appropriately qualified healthcare professional based on the intended clinical purpose and individual circumstances.
Contraindications
The supplied source identifies the following contraindications and precautions:

Hypersensitivity to any component
Pregnancy
Lactation
Acute psychosis
Anxiety disorders
History of seizures
Children under 5 years of age

The source also advises caution when combining N-Acetyl Semax with other stimulants or nootropic agents.
Side Effects
According to the supplied product information, side effects are described as uncommon when the product is used correctly. The source reports mild nasopharyngeal discomfort following intranasal administration and mild swelling at the injection site in a small number of patients.
About Hilma Biocare USA
N-Acetyl Semax 50 mg/vial is part of the Hilma Biocare product range. It is supplied as an injection/powder formulation containing 50 mg of N-Acetyl Semax per vial and is listed as US Stock.
Important Information
N-Acetyl Semax is a biologically active neuropeptide. The supplied source contains detailed therapeutic dosing schedules for specific neurological conditions; those actionable dosing instructions are not reproduced here.
The information on this page is based on the supplied product description and is intended as product information rather than individualized medical advice. Anyone considering N-Acetyl Semax should consult an appropriately qualified healthcare professional regarding suitability, administration, contraindications, potential interactions, and applicable regulations.